120 related articles for article (PubMed ID: 2550954)
1. Long term administration of dopamine: is there a development of tolerance?
Braun GG; Bahlmann F; Brandl M; Knoll R
Prog Clin Biol Res; 1989; 308():1097-9. PubMed ID: 2550954
[No Abstract] [Full Text] [Related]
2. Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure.
Goldberg LI
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S21-8. PubMed ID: 2483439
[TBL] [Abstract][Full Text] [Related]
3. Similarities and differences of dopamine receptors in the renal vascular bed and elsewhere.
Goldberg LI; Volkman PH; Kohli JD; Kotake AN
Adv Biochem Psychopharmacol; 1977; 16():251-6. PubMed ID: 196488
[No Abstract] [Full Text] [Related]
4. The use of low doses of dopamine in intensive care medicine.
D'Orio V; el Allaf D; Juchmès J; Marcelle R
Arch Int Physiol Biochim; 1984 Nov; 92(4):S11-20. PubMed ID: 6085236
[TBL] [Abstract][Full Text] [Related]
5. [The cardiovascular system and adrenergic inhibition].
Arkatov VA; Korotkoruchko AA
Anesteziol Reanimatol; 1986; (5):70-4. PubMed ID: 2880533
[No Abstract] [Full Text] [Related]
6. New perspectives in cardiopulmonary therapeutics: receptor-selective adrenergic drugs.
Adams HR
J Am Vet Med Assoc; 1984 Nov; 185(9):966-74. PubMed ID: 6150925
[TBL] [Abstract][Full Text] [Related]
7. [Effect of anticholinergics on cardiovascular reactivity in subjects with essential arterial hypertension being administered a sympathetic agonist].
Bubueanu G; Filcescu V; Moisin C; Popa-Mare A; Drăgulescu N; Petec F; Atanasiu M; Curcă F
Physiologie; 1988; 25(4):191-9. PubMed ID: 2853373
[No Abstract] [Full Text] [Related]
8. Evaluation of the alpha and beta adrenoceptor-mediated activities of the novel, orally active inotropic agent, ibopamine, in the cardiovascular system of the pithed rat: comparison with epinine and dopamine.
Nichols AJ; Ruffolo RR
J Pharmacol Exp Ther; 1987 Aug; 242(2):455-63. PubMed ID: 3039117
[TBL] [Abstract][Full Text] [Related]
9. [Dopaminergic stimulation in cardiology: its current status and future strategies].
Cherchi A; Mercuro G
Cardiologia; 1987 Dec; 32(12):1631-9. PubMed ID: 3329022
[No Abstract] [Full Text] [Related]
10. Interaction of the novel inotropic agent, ASL-7022, with alpha and beta adrenoceptors in the cardiovascular system of the pithed rat: comparison with dobutamine and dopamine.
Ruffolo RR; Morgan EL
J Pharmacol Exp Ther; 1984 May; 229(2):364-71. PubMed ID: 6325661
[TBL] [Abstract][Full Text] [Related]
11. Dopamine: pharmacologic and therapeutic aspects.
Velasco M; Luchsinger A
Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological explanation of dopamine (author's transl)].
Shigiya R; Seta K; Arisaka M; Tsunoda K; Watabe M
Kokyu To Junkan; 1973 Dec; 21(12):1113-6. PubMed ID: 4148952
[No Abstract] [Full Text] [Related]
13. Identification and characterization of dopamine receptors in the cardiovascular system.
Goldberg LI; Kohli JD
Cardiologia; 1987 Dec; 32(12):1603-7. PubMed ID: 3447717
[No Abstract] [Full Text] [Related]
14. In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol.
Hayes JS; Pollock GD; Fuller RW
J Pharmacol Exp Ther; 1984 Dec; 231(3):633-9. PubMed ID: 6094797
[TBL] [Abstract][Full Text] [Related]
15. Adrenergic receptors and catecholamine effects on sodium transport in the mammalian nephron.
Cohen HT; Katz AI
Semin Nephrol; 1991 Mar; 11(2):110-9. PubMed ID: 1674621
[No Abstract] [Full Text] [Related]
16. [Peripheral dopamine DA1-type receptors: their localization, functional role and possible clinical implications].
Mannelli M; Pupilli C; Baldi E; DeFeo ML
Cardiologia; 1987 Dec; 32(12):1617-21. PubMed ID: 2965980
[No Abstract] [Full Text] [Related]
17. [Clinical efficacy of oral dopaminergic agents: new findings].
Dei Cas L; Metra M; Nodari S; Raccagni D
Cardiologia; 1995 Dec; 40(12 Suppl 1):131-8. PubMed ID: 8998705
[No Abstract] [Full Text] [Related]
18. [Piracetam and the activity of alpha- and beta-adrenergic, dopaminergic and muscarine cholinergic receptors (author's transl)].
Atanacković D; Simonić A
Lijec Vjesn; 1981 Dec; 103(12):545-9. PubMed ID: 6285100
[No Abstract] [Full Text] [Related]
19. Administration of inotropes.
Davies N
Nurs Times; 2001 Jul 19-25; 97(29):36-7. PubMed ID: 11957503
[No Abstract] [Full Text] [Related]
20. [Mechanism of action of ibopamine: pharmacological effects of epinine and other metabolites].
Ferrini R; Merlo L; Miragoli G
Cardiologia; 1988 Jan; 33(1):49-53. PubMed ID: 2835159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
